<p>REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clo
TitleNZDUSD H4 | Bearish reversal off 50% Fibo resistanceTypeBearish ReversalPreference:Price is rising towards the pivot point of 0.5947 which is a pullback resistance that aligns with the 50.0% Fib
Leave a Comment